Starling Oncology Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 641

Employees

  • Stock Symbol
  • STLN

Stock Symbol

  • Investments
  • 16

  • Share Price
  • $3.72
  • (As of Thursday Closing)

Starling Oncology General Information

Description

Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

Contact Information

Formerly Known As
The Oncology Institute
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 18000 Studebaker Road
  • Suite 800
  • Cerritos, CA 90703
  • United States
Primary Industry
Hospitals/Inpatient Services
Other Industries
Clinics/Outpatient Services
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 18000 Studebaker Road
  • Suite 800
  • Cerritos, CA 90703
  • United States

Starling Oncology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starling Oncology Stock Performance

As of 12-Nov-2026, Starling Oncology’s stock price is $3.72. Its current market cap is $382M with 102M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.72 $4.20 $2.32 - $7.13 $382M 102M 1.94M -$0.29

Starling Oncology Financials Summary

As of 30-Sep-2026, Starling Oncology has a trailing 12-month revenue of $620M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 707,492 426,131 98,896 180,383
Revenue 620,447 502,729 393,412 324,239
EBITDA (18,524) (42,517) (50,880) (70,454)
Net Income (35,537) (60,606) (64,663) (83,068)
Total Assets 187,773 164,656 172,717 209,240
Total Debt 102,730 103,687 123,152 119,675
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Starling Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Starling Oncology‘s full profile, request access.

Request a free trial

Starling Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and t
Hospitals/Inpatient Services
Cerritos, CA
641 As of 2025

Fort Myers, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Starling Oncology Competitors (1)

One of Starling Oncology’s competitors is Florida Cancer Specialists & Research Institute, a Venture Capital-Backed company based in Fort Myers, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Florida Cancer Specialists & Research Institute Venture Capital-Backed Fort Myers, FL
You’re viewing 1 of 1 competitors. Get the full list »

Starling Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Starling Oncology Investments & Acquisitions (16)

Starling Oncology’s most recent deal was a Corporate Asset Purchase with Bolsa Pharmacy (Clinical and Non-clinical Assets) for . The deal was made on 28-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bolsa Pharmacy (Clinical and Non-clinical Assets) 28-Nov-2023 Corporate Asset Purchase Buildings and Property
Southland Radiation Oncology Network 05-Jun-2023 Merger/Acquisition Other Healthcare Services
The South Miami Clinic 22-Nov-2022 Merger/Acquisition Clinics/Outpatient Services
Intercommunity Oncology of Chino Hills 21-Nov-2022 Merger/Acquisition Clinics/Outpatient Services
Broward Oncology Associates 30-Aug-2022 Merger/Acquisition Buildings and Property
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

Starling Oncology ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

29.49 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Services

Subindustry

of 97

Rank

Percentile

To view Starling Oncology’s complete esg history, request access »

Starling Oncology FAQs

  • When was Starling Oncology founded?

    Starling Oncology was founded in 2007.

  • Where is Starling Oncology headquartered?

    Starling Oncology is headquartered in Cerritos, CA.

  • What is the size of Starling Oncology?

    Starling Oncology has 641 total employees.

  • What industry is Starling Oncology in?

    Starling Oncology’s primary industry is Hospitals/Inpatient Services.

  • Is Starling Oncology a private or public company?

    Starling Oncology is a Public company.

  • What is Starling Oncology’s stock symbol?

    The ticker symbol for Starling Oncology is STLN.

  • What is the current stock price of Starling Oncology?

    As of 12-Nov-2026 the stock price of Starling Oncology is $3.72.

  • What is the current market cap of Starling Oncology?

    The current market capitalization of Starling Oncology is $382M.

  • What is Starling Oncology’s current revenue?

    The trailing twelve month revenue for Starling Oncology is $620M.

  • Who are Starling Oncology’s competitors?

    Florida Cancer Specialists & Research Institute is a competitor of Starling Oncology.

  • What is Starling Oncology’s annual earnings per share (EPS)?

    Starling Oncology’s EPS for 12 months was -$0.29.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process